Skip to content

DR. INE LIBBRECHT: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

DR. INE LIBBRECHT

BE 0477.498.336
NACE 86.220, Specialist medical practice
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€160,808
2024 · €92,357+€68,451
Equity
€853,870
2024 · €694,728+€159,142
Cash
€14,016
2024 · €33,075-€19,059
Balance sheet total
€1.3m
2024 · €1.1m+€115,715

Largest movements

2024 to 2025
Assets
  • Deferred charges and accrued income +€93,075

    up €93,075 (+252%), from €36,898 to €129,973

  • Tangible fixed assets +€61,524

    up €61,524 (+7.7%), from €799,931 to €861,455

    of which Land and buildings: +€62,583

  • Current investments -€20,000

    down €20,000 (-7.4%), from €270,000 to €250,000

  • Cash -€19,059

    down €19,059 (-57.6%), from €33,075 to €14,016

    mainly Deferred charges and accrued income (-€93,075) and Investment in fixed assets (net) (-€92,234)

Equity and liabilities
  • Reserves +€159,142

    up €159,142 (+22.9%), from €694,728 to €853,870

    of which Distributable reserves: +€114,937

  • Debts after one year -€28,872

    down €28,872 (-9.8%), from €295,935 to €267,063

    of which Financial debts: -€28,872

  • Other debts -€21,897

    down €21,897 (-33.0%), from €66,319 to €44,421

Income statement
  • Gross operating margin +€113,067

    up €113,067 (+50.2%), from €225,227 to €338,293

  • Taxes +€26,067

    up €26,067 (+64.7%), from €40,318 to €66,385

  • Financial charges +€5,473

    up €5,473 (+13.5%), from €40,659 to €46,132

  • Financial income -€5,335

    down €5,335 (-80.2%), from €6,654 to €1,319

  • Staff costs +€5,073

    up €5,073 (+20.6%), from €24,678 to €29,751

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €92,357
Gross operating margin +€113,067
Staff costs -€5,073
Depreciation -€3,147
Other operating charges +€478
Financial income -€5,335
Financial charges -€5,473
Taxes -€26,067
Result 2025 €160,808
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€81,569
Investment -€72,234
Financing -€28,394
Cash 2024 €33,075
Net result for the year +€160,808
Depreciation +€30,710
Receivables within one year -€175
Deferred charges and accrued income -€93,075
Trade debts +€2,305
Tax, wage and social debts +€5,165
Other debts -€21,897
Accrued charges and deferred income -€2,273
Investment in fixed assets (net) -€92,234
Current investments +€20,000
Debts after one year -€28,872
Current portion of long-term debt +€511
Short-term financial debts +€1,633
Contributions, distributions and other -€1,666
Cash 2025 €14,016
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,140,005 €1,255,719 +€115,715 +10.2%
Fixed assets 21/28 €799,931 €861,455 +€61,524 +7.7%
Tangible fixed assets 22/27 €799,931 €861,455 +€61,524 +7.7%
Land and buildings 22 €795,187 €857,770 +€62,583 +7.9%
Plant, machinery and equipment 23 €4,744 €3,685 -€1,059 -22.3%
Current assets 29/58 €340,074 €394,264 +€54,191 +15.9%
Amounts receivable within one year 40/41 €101 €276 +€175 +173%
Trade receivables 40 €101 €276 +€175 +173%
Current investments 50/53 €270,000 €250,000 -€20,000 -7.4%
Cash at bank and in hand 54/58 €33,075 €14,016 -€19,059 -57.6%
Deferred charges and accrued income 490/1 €36,898 €129,973 +€93,075 +252%
Total equity and liabilities 10/49 €1,140,005 €1,255,719 +€115,715 +10.2%
Equity 10/15 €694,728 €853,870 +€159,142 +22.9%
Reserves 13 €694,728 €853,870 +€159,142 +22.9%
Tax-exempt reserves 132 - €44,205 +€44,205
Distributable reserves 133 €694,728 €809,665 +€114,937 +16.5%
Amounts payable 17/49 €445,277 €401,849 -€43,428 -9.8%
Amounts payable after more than one year 17 €295,935 €267,063 -€28,872 -9.8%
Financial debts 170/4 €45,935 €17,063 -€28,872 -62.9%
Other amounts payable 178/9 €250,000 €250,000 = 0.0%
Amounts payable within one year 42/48 €129,112 €116,829 -€12,283 -9.5%
Current portion of amounts payable after more than one year 42 €30,745 €31,256 +€511 +1.7%
Financial debts 43 €8,486 €10,119 +€1,633 +19.2%
Credit institutions 430/8 €8,486 €10,119 +€1,633 +19.2%
Trade debts 44 €1,851 €4,155 +€2,305 +125%
Suppliers 440/4 €1,851 €4,155 +€2,305 +125%
Taxes, remuneration and social security 45 €21,712 €26,877 +€5,165 +23.8%
Taxes 450/3 €13,322 €15,489 +€2,167 +16.3%
Remuneration and social security 454/9 €8,390 €11,388 +€2,998 +35.7%
Other amounts payable 47/48 €66,319 €44,421 -€21,897 -33.0%
Accrued charges and deferred income 492/3 €20,230 €17,957 -€2,273 -11.2%
Remuneration, social security and pensions 62 €24,678 €29,751 +€5,073 +20.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €27,564 €30,710 +€3,147 +11.4%
Other operating charges 640/8 €6,304 €5,826 -€478 -7.6%
Gross operating margin 9900 €225,227 €338,293 +€113,067 +50.2%
Operating profit (loss) 9901 €166,681 €272,006 +€105,325 +63.2%
Financial income 75/76B €6,654 €1,319 -€5,335 -80.2%
Recurring financial income 75 €6,654 €1,319 -€5,335 -80.2%
Financial charges 65/66B €40,659 €46,132 +€5,473 +13.5%
Recurring financial charges 65 €40,659 €46,132 +€5,473 +13.5%
Profit (loss) for the period before taxes 9903 €132,675 €227,193 +€94,518 +71.2%
Income taxes 67/77 €40,318 €66,385 +€26,067 +64.7%
Profit (loss) for the period 9904 €92,357 €160,808 +€68,451 +74.1%
Transfer to tax-exempt reserves 689 - €44,205 +€44,205
Profit (loss) for the period to be appropriated 9905 €92,357 €116,603 +€24,246 +26.3%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.